# Adagene Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:b925afbb-e483-491c-b195-7a680f06601e | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/adagene-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 2 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:43.578776+00:00 | | Last reviewed | 2026-10-17T04:46:43.578776+00:00 | ## Identity - Legal name: Adagene Inc. - Display name: Adagene Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T08:19:47.409209+00:00 | | Completeness | 0.364 | | Record Quality | 0.8 | | Directors | 6 | | Committees | 1 | | Governance events | 0 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | INSUFFICIENT_EVIDENCE | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Andy (Yiu Leung) Cheung: Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:8 - Cuong Do: Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:9 - Li Zhu, Ph.D.: Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:10 - Man Kin (Raymond) Tam, M.B.A., B. Eng.: Chief Financial Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:11 - Peter Luo, Ph.D: Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer, President of R&D, and Chairman of the Board (member). claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:7 - Ulf Grawunder, Ph.D.: Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:12 ## Committees - Chief Executive Officer, President of R&D, and Chairman of the Board (executive). Chair: NOT_PUBLISHED. Members: Peter Luo, Ph.D (member, unknown). committee_id=alpha:committee:adagene-inc:chief-executive-officer-president-of-r-d-and-chairman-of-the-board ## Executive leadership - Alexander Goergen: Vice President, Head of Business Development. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:13 - Guizhong Liu, Ph.D.: Senior Vice President of Early Drug Discovery. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:14 - Jiping Zha: Executive Vice President of Clinical Development. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:15 - Man Kin (Raymond) Tam, M.B.A., B. Eng.: Chief Financial Officer and Director [CFO]. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:16 - Mickael Chane-Du: Chief Strategy Officer. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:17 - Peter Luo, Ph.D: Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board [CEO]. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:18 - Qinghai Zhao, Ph.D: Chief Manufacturing Officer. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:19 - Songmao Zheng, Ph.D.: Senior Vice President of Clinical Pharmacology and Quantitative Sciences. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:20 - Wenlin Zeng: Vice President of Early Stage CMC. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:21 - Xiaohong (Kristine) She: Senior Vice President, Head of Clinical Operations. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:22 - Yan Li, M.B.A.: Senior Vice President, Bioinformatics and Information Technology. Status: unknown. claim_id=alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:23 ## Scoped resources - `alpha://company/adagene-inc` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record - `alpha://company/adagene-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=identity - `alpha://company/adagene-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=corporate-structure - `alpha://company/adagene-inc/board` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=board - `alpha://company/adagene-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=committees - `alpha://company/adagene-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=leadership - `alpha://company/adagene-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=ownership - `alpha://company/adagene-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=financials - `alpha://company/adagene-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=capital-structure - `alpha://company/adagene-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=compensation - `alpha://company/adagene-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=governance - `alpha://company/adagene-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=shareholder-governance - `alpha://company/adagene-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=audit - `alpha://company/adagene-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=legal - `alpha://company/adagene-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=risk - `alpha://company/adagene-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=cyber - `alpha://company/adagene-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=ai-governance - `alpha://company/adagene-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=agents - `alpha://company/adagene-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=ecosystem - `alpha://company/adagene-inc/events` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=events - `alpha://company/adagene-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=relationships - `alpha://company/adagene-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=assessments - `alpha://company/adagene-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/adagene-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Peter Luo, Ph.D: Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Andy (Yiu Leung) Cheung: Independent Director. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Cuong Do: Independent Director. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Li Zhu, Ph.D.: Independent Director. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Man Kin (Raymond) Tam, M.B.A., B. Eng.: Chief Financial Officer and Director. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Ulf Grawunder, Ph.D.: Independent Director. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Alexander Goergen: Vice President, Head of Business Development. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Guizhong Liu, Ph.D.: Senior Vice President of Early Drug Discovery. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Jiping Zha: Executive Vice President of Clinical Development. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Man Kin (Raymond) Tam, M.B.A., B. Eng.: Chief Financial Officer and Director. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Mickael Chane-Du: Chief Strategy Officer. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Peter Luo, Ph.D: Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Qinghai Zhao, Ph.D: Chief Manufacturing Officer. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Songmao Zheng, Ph.D.: Senior Vice President of Clinical Pharmacology and Quantitative Sciences. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Wenlin Zeng: Vice President of Early Stage CMC. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Xiaohong (Kristine) She: Senior Vice President, Head of Clinical Operations. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. - Yan Li, M.B.A.: Senior Vice President, Bioinformatics and Information Technology. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Adagene Inc.. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3. ## Entity Status - Public listing published. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3. ## Published Fact - US. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3. - Healthcare. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3. - Biotechnology. Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3. ## Security Listing - ADAG (NASDAQ). Claim: alpha:claim:company:b925afbb-e483-491c-b195-7a680f06601e:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:0f26c5505655ce64c9bdc33e94d716e931e27cd9b41dfb26819751bb2e6629b3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/adagene-inc). - alpha:projection-evidence:document:f276a1140098ae9edae2074a07f2d41c2e5c7bf916e7b729e59b3246fff3e322: [SEC 20-F 0001104659-26-038612](https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/adagene-inc) - [Public Markdown](https://registry.alpha.ac/companies/adagene-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/adagene-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/adagene-inc?format=jsonld) - MCP resource: `alpha://companies/adagene-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T08:19:47.215679+00:00; recorded 2026-10-17T08:19:47.215679+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.